Coronary artery bypass surgery end stage renal Disease



==ACCF/AHA Guidelines for CABG in Patients with End Stage Renal Disease == {{cquote|

Class IIb
1. CABG to improve survival rate may be reasonable in patients with end stage renal disease undergoing CABG for left main coronary artery stenosis of greater than or equal to 50%. (Level of Evidence: C)

2. CABG to improve survival rate or to relieve angina despite GDMT may be reasonable for patients with end-stage renal disease with significant stenoses (≥70%) in 3 major vessels or in the proximal LAD artery plus 1 other major vessel, regardless of LV systolic function. (Level of Evidence: B)

Class III: HARM
1. CABG should not be performed in patients with end-stage renal disease whose life expectancy is limited by noncardiac issues. (Level of Evidence: C)}}

Guidelines Resources

 * 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery : A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines